Report

Global Bioprocess Analyzers Market Size study & Forecast, by Product, Application, Type, and Regional Analysis, 2022-2029

  • Publish Date: Feb,2023
  • Report ID: 3-2-1557
  • Page : 200
  • Report Type : PDF (Email)
Global Bioprocess Analyzers Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.1% over the forecast period 2022-2029. Bioprocess Analyzers help in the quick analysis of many properties with rapid measurement of the whole bioprocess. The Bioprocess Analyzers market is expanding because of factors such as growing interest in the development of advanced medicines and vaccines and increasing demand for biologics. This market is dominated by F. Hoffmann-La Roche AG, Nova Biomedical Corporation, YSI Inc., and Randox Laboratories Ltd.

This market has been seeing significant growth in the past few years due to the growing interest from fields such as pharmacology, toxicology, and biotechnology in the development of advanced pharmaceutical products and vaccines, and rising demand for mammalian protein production are also major factors driving the growth of the market. As recombinant proteins, they are used not only in biomedical research but also in therapy and are in increasing demand as pharmaceuticals and are increasing with production. In addition, Recombinant Protein is expected to increase the opportunity for this significant market. However, the technical issues and cost factor may stifle the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bioprocess Analyzers Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. In December 2021, the alliance of public and private organizations helping create a progressive pharmaceutical cluster in central Virginia has been named a finalist in the Economic Development Authority's (EDA) $1 billion Build Back Better Regional Challenge campaign. This alliance is expected to advance the development and expansion of the advanced pharmaceutical industry in central Virginia. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

F. Hoffmann-La Roche Ltd

Sartorious AG

Agilent Technologies India Pvt Ltd

YSI Inc.

Randox Laboratories Ltd

Thermo Fisher Scientific Inc

Nova Biomedical Corporation

Polestar Technologies

Groton Biosystems

Recent Developments in the Market:

In June 2019, Biogenuix Medsystems Private Limited launched Cypher One, an automated heme agglutination analyzer, a high-throughput, one-step solution for rapid and automated analysis of heme aggregation (HA) and heme inhibition (HAI) assays. has been released.
In September 2021, Merck's Life Sciences business launched the ProCellics Raman Analyzer with Bio4C PAT Raman software. GMP-compliant platforms provide in-line and real-time monitoring of critical process parameters and critical cell culture quality attributes in upstream development and manufacturing of monoclonal antibody and vaccine processes. It is specially made for the bioprocessing industry.
Global Bioprocess Analyzers Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Application, Type, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Instrument

Consumable

By Application:

Antibiotics

Recombinant Proteins

Biosimilars

Other Applications

By Type:

Substrate Analysis

Metabolite Analysis

Concentration Detection

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World